| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.967 | 0.001 | 0.967 | Fibroblast growth factor 2 antagonist | 0.895 0.001 DBMET03649 0.783 0.001 DBMET03650 | ||
| 0.963 | 0.002 | 0.963 | Fibroblast growth factor 1 antagonist | 0.92 0.002 DBMET03649 0.777 0.003 DBMET03650 | ||
| 0.96 | 0.001 | 0.96 | Fibroblast growth factor 3 antagonist | 0.89 0.001 DBMET03649 0.745 0.001 DBMET03650 | ||
| 0.946 | 0.001 | 0.946 | Fibroblast growth factor 4 antagonist | 0.862 0.001 DBMET03649 0.528 0.002 DBMET03650 | ||
| 0.945 | 0.004 | 0.945 | Growth factor antagonist | 0.894 0.004 DBMET03649 0.924 0.004 DBMET03650 | ||
| 0.895 | 0.004 | 0.895 | Vascular endothelial growth factor antagonist | 0.829 0.004 DBMET03649 0.79 0.004 DBMET03650 | ||
| 0.894 | 0.004 | 0.894 | Vascular endothelial growth factor 2 antagonist | 0.83 0.004 DBMET03649 0.783 0.004 DBMET03650 | ||
| 0.847 | 0.004 | 0.847 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.798 0.004 DBMET03649 0.699 0.005 DBMET03650 | ||
| 0.778 | 0.005 | 0.781 | Angiogenesis inhibitor | 0.73 0.008 DBMET03649 0.781 0.005 DBMET03650 | DBMET03650 | |
| 0.429 | 0.025 | 0.723 | Tyrosine kinase inhibitor | 0.326 0.038 DBMET03649 0.723 0.005 DBMET03650 | DBMET03650 | |
| 0.444 | 0.081 | 0.695 | MAP kinase 1 inhibitor | 0.386 0.115 DBMET03649 0.695 0.005 DBMET03650 | DBMET03650 | |
| 0.317 | 0.012 | 0.49 | Heat shock protein 90 alpha antagonist | 0.403 0.005 DBMET03649 0.49 0.004 DBMET03650 | DBMET03650 | |
| 0.314 | 0.031 | 0.621 | EphB2 antagonist | 0.294 0.037 DBMET03649 0.621 0.004 DBMET03650 | DBMET03650 | |
| 0.272 | 0.015 | 0.4 | Heat shock protein 90 antagonist | 0.352 0.005 DBMET03649 0.4 0.004 DBMET03650 | DBMET03650 | |
| 0.321 | 0.116 | 0.447 | MAP kinase kinase 6 inhibitor | 0.29 0.145 DBMET03649 0.447 0.035 DBMET03650 | DBMET03650 | |
| 0.281 | 0.097 | 0.318 | Sodium/bile acid cotransporter inhibitor | 0.318 0.064 DBMET03649 | DBMET03649 | |
| 0.195 | 0.012 | 0.303 | Hepatocyte growth factor antagonist | 0.177 0.015 DBMET03649 0.303 0.004 DBMET03650 | DBMET03650 | |
| 0.219 | 0.058 | 0.427 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.208 0.066 DBMET03649 0.427 0.009 DBMET03650 | DBMET03650 | |
| 0.195 | 0.048 | 0.307 | Polo-like kinase-3 inhibitor | 0.174 0.062 DBMET03649 0.307 0.01 DBMET03650 | DBMET03650 | |
| 0.183 | 0.077 | 0.327 | TRKC antagonist | 0.163 0.091 DBMET03649 0.327 0.02 DBMET03650 | DBMET03650 | |
| 0.138 | 0.035 | 0.262 | Activin receptor-like kinase 4 inhibitor | 0.123 0.048 DBMET03649 0.262 0.007 DBMET03650 | DBMET03650 | |
| 0.129 | 0.027 | 0.275 | Leucine-rich repeat kinase 2 inhibitor | 0.073 0.065 DBMET03649 0.275 0.005 DBMET03650 | DBMET03650 | |
| 0.174 | 0.079 | 0.402 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.155 0.091 DBMET03649 0.402 0.011 DBMET03650 | DBMET03650 | |
| 0.179 | 0.089 | 0.29 | Focal adhesion kinase 2 inhibitor | 0.29 0.019 DBMET03650 | DBMET03650 | |
| 0.194 | 0.111 | 0.322 | MAP-kinase-activated kinase 5 inhibitor | 0.199 0.105 DBMET03649 0.322 0.019 DBMET03650 | DBMET03650 | |
| 0.14 | 0.059 | 0.329 | Protein kinase (CK1) delta inhibitor | 0.113 0.079 DBMET03649 0.329 0.01 DBMET03650 | DBMET03650 | |
| 0.108 | 0.038 | 0.188 | Polo-like kinase-1 inhibitor | 0.087 0.067 DBMET03649 0.188 0.008 DBMET03650 | DBMET03650 | |
| 0.139 | 0.071 | 0.373 | Protein-tyrosine kinase Lyn inhibitor | 0.117 0.087 DBMET03649 0.373 0.009 DBMET03650 | DBMET03650 | |
| 0.12 | 0.053 | 0.457 | Granulocyte macrophage colony stimulating factor antagonist | 0.457 0.004 DBMET03650 | DBMET03650 | |
| 0.106 | 0.04 | 0.185 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.087 0.06 DBMET03649 0.185 0.012 DBMET03650 | DBMET03650 | |
| 0.08 | 0.016 | 0.135 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.063 0.024 DBMET03649 0.135 0.005 DBMET03650 | DBMET03650 | |
| 0.094 | 0.031 | 0.114 | Polo-like kinase-2 inhibitor | 0.081 0.043 DBMET03649 0.114 0.014 DBMET03650 | DBMET03650 | |
| 0.077 | 0.015 | 0.077 | Myc inhibitor | 0.072 0.018 DBMET03649 0.049 0.047 DBMET03650 | ||
| 0.167 | 0.106 | 0.348 | Antimitotic | 0.167 0.106 DBMET03649 0.348 0.033 DBMET03650 | DBMET03650 | |
| 0.232 | 0.172 | 0.433 | GABA C receptor rho-3 antagonist | 0.264 0.142 DBMET03649 0.433 0.048 DBMET03650 | DBMET03650 | |
| 0.13 | 0.072 | 0.37 | RET inhibitor | 0.115 0.082 DBMET03649 0.37 0.013 DBMET03650 | DBMET03650 | |
| 0.12 | 0.065 | 0.448 | Aurora-B kinase inhibitor | 0.448 0.005 DBMET03650 | DBMET03650 | |
| 0.075 | 0.02 | 0.089 | Kallikrein 7 inhibitor | 0.071 0.027 DBMET03649 0.089 0.008 DBMET03650 | DBMET03650 | |
| 0.08 | 0.027 | 0.166 | Aryl hydrocarbon receptor antagonist | 0.071 0.036 DBMET03649 0.166 0.004 DBMET03650 | DBMET03650 | |
| 0.096 | 0.043 | 0.227 | AXL receptor tyrosine kinase inhibitor | 0.077 0.065 DBMET03649 0.227 0.006 DBMET03650 | DBMET03650 | |
| 0.094 | 0.046 | 0.214 | ErbB-3 antagonist | 0.076 0.066 DBMET03649 0.214 0.008 DBMET03650 | DBMET03650 | |
| 0.203 | 0.158 | 0.209 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.209 0.141 DBMET03650 | DBMET03650 | |
| 0.086 | 0.045 | 0.254 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.087 0.044 DBMET03649 0.254 0.009 DBMET03650 | DBMET03650 | |
| 0.08 | 0.04 | 0.248 | Syk tyrosine kinase inhibitor | 0.069 0.051 DBMET03649 0.248 0.005 DBMET03650 | DBMET03650 | |
| 0.1 | 0.063 | 0.28 | Ephrin antagonist | 0.089 0.073 DBMET03649 0.28 0.011 DBMET03650 | DBMET03650 | |
| 0.111 | 0.076 | 0.304 | TRKA antagonist | 0.304 0.012 DBMET03650 | DBMET03650 | |
| 0.161 | 0.128 | 0.161 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.082 | 0.049 | 0.267 | MAP kinase 10 inhibitor | 0.267 0.005 DBMET03650 | DBMET03650 | |
| 0.097 | 0.065 | 0.332 | Platelet activating factor beta antagonist | 0.332 0.009 DBMET03650 | DBMET03650 | |
| 0.073 | 0.043 | 0.211 | Check point kinase 1 inhibitor | 0.077 0.04 DBMET03649 0.211 0.009 DBMET03650 | DBMET03650 | |
| 0.113 | 0.082 | 0.258 | TRKB antagonist | 0.258 0.015 DBMET03650 | DBMET03650 | |
| 0.075 | 0.047 | 0.304 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.304 0.005 DBMET03650 | DBMET03650 | |
| 0.072 | 0.045 | 0.131 | Transforming growth factor antagonist | 0.131 0.009 DBMET03650 | DBMET03650 | |
| 0.073 | 0.054 | 0.092 | Protein kinase B gamma inhibitor | 0.092 0.037 DBMET03650 | DBMET03650 | |
| 0.089 | 0.07 | 0.189 | Platelet activating factor alpha antagonist | 0.189 0.019 DBMET03650 | DBMET03650 | |
| 0.266 | 0.249 | 0.579 | Antiinflammatory | 0.312 0.204 DBMET03649 0.579 0.059 DBMET03650 | DBMET03650 | |
| 0.052 | 0.036 | 0.09 | mTOR inhibitor | 0.052 0.035 DBMET03649 0.09 0.014 DBMET03650 | DBMET03650 | |
| 0.065 | 0.049 | 0.186 | MAP kinase kinase 10 inhibitor | 0.186 0.007 DBMET03650 | DBMET03650 | |
| 0.127 | 0.115 | 0.245 | MAP kinase 3 inhibitor | 0.245 0.009 DBMET03650 | DBMET03650 | |
| 0.082 | 0.072 | 0.164 | Pim-3 kinase inhibitor | 0.164 0.014 DBMET03650 | DBMET03650 | |
| 0.11 | 0.1 | 0.309 | Protein kinase (CK1) inhibitor | 0.309 0.016 DBMET03650 | DBMET03650 | |
| 0.057 | 0.049 | 0.086 | Phosphodiesterase 1A inhibitor | 0.086 0.014 DBMET03650 | DBMET03650 | |
| 0.105 | 0.097 | 0.263 | Lck kinase inhibitor | 0.263 0.022 DBMET03650 | DBMET03650 | |
| 0.063 | 0.057 | 0.097 | ZAP-70 protein tyrosine kinase inhibitor | 0.097 0.016 DBMET03650 | DBMET03650 | |
| 0.149 | 0.144 | 0.237 | Growth factor agonist | 0.237 0.038 DBMET03650 | DBMET03650 | |
| 0.074 | 0.07 | 0.18 | Insulin like growth factor 1 antagonist | 0.18 0.013 DBMET03650 | DBMET03650 | |
| 0.121 | 0.117 | 0.264 | Cyclin-dependent kinase 8 inhibitor | 0.264 0.013 DBMET03650 | DBMET03650 | |
| 0.08 | 0.078 | 0.186 | Phosphodiesterase I inhibitor | 0.186 0.012 DBMET03650 | DBMET03650 | |
| 0.051 | 0.049 | 0.218 | EphB4 antagonist | 0.218 0.006 DBMET03650 | DBMET03650 | |
| 0.043 | 0.042 | 0.152 | Transforming growth factor beta 1 antagonist | 0.152 0.005 DBMET03650 | DBMET03650 | |
| 0.065 | 0.064 | 0.216 | ErbB-4 antagonist | 0.216 0.011 DBMET03650 | DBMET03650 | |
| 0.104 | 0.104 | 0.309 | Tyrosine-protein kinase receptor antagonist | 0.309 0.016 DBMET03650 | DBMET03650 | |
| 0.075 | 0.075 | 0.185 | Insulin growth factor antagonist | 0.185 0.014 DBMET03650 | DBMET03650 | |
| 0.033 | 0.036 | 0.04 | ATM kinase inhibitor | 0.04 0.018 DBMET03650 | DBMET03650 | |
| 0.056 | 0.061 | 0.106 | Phosphodiesterase 1C inhibitor | 0.106 0.009 DBMET03650 | DBMET03650 | |
| 0.108 | 0.113 | 0.312 | Activin receptor-like kinase 2 inhibitor | 0.312 0.011 DBMET03650 | DBMET03650 | |
| 0.051 | 0.058 | 0.13 | Phosphodiesterase 1B inhibitor | 0.13 0.009 DBMET03650 | DBMET03650 | |
| 0.111 | 0.118 | 0.331 | Src kinase inhibitor | 0.331 0.021 DBMET03650 | DBMET03650 | |
| 0.086 | 0.093 | 0.245 | Platelet activating factor antagonist | 0.245 0.017 DBMET03650 | DBMET03650 | |
| 0.01 | 0.02 | 0.017 | 5 Lipoxygenase activating protein inhibitor | 0.017 0.006 DBMET03650 | DBMET03650 | |
| 0.144 | 0.154 | 0.231 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.231 0.071 DBMET03650 | DBMET03650 | |
| 0.118 | 0.13 | 0.204 | GABA C receptor rho-2 antagonist | 0.204 0.027 DBMET03650 | DBMET03650 | |
| 0.075 | 0.088 | 0.187 | Check point kinase 2 inhibitor | 0.187 0.02 DBMET03650 | DBMET03650 | |
| 0.048 | 0.063 | 0.153 | Cyclin A2 inhibitor | 0.153 0.013 DBMET03650 | DBMET03650 | |
| 0.044 | 0.063 | 0.151 | Cyclin A inhibitor | 0.151 0.013 DBMET03650 | DBMET03650 | |
| 0.027 | 0.048 | 0.042 | Transforming growth factor beta 2 antagonist | 0.042 0.011 DBMET03650 | DBMET03650 | |
| 0.067 | 0.09 | 0.192 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.192 0.024 DBMET03650 | DBMET03650 | |
| 0.042 | 0.066 | 0.195 | Tyk2 inhibitor | 0.195 0.009 DBMET03650 | DBMET03650 | |
| 0.071 | 0.095 | 0.271 | Aurora-A kinase inhibitor | 0.271 0.015 DBMET03650 | DBMET03650 | |
| 0.039 | 0.064 | 0.102 | Tyrosine-protein kinase EMT inhibitor | 0.102 0.017 DBMET03650 | DBMET03650 | |
| 0.029 | 0.054 | 0.113 | Phosphodiesterase X inhibitor | 0.113 0.009 DBMET03650 | DBMET03650 | |
| 0.029 | 0.054 | 0.113 | Phosphodiesterase 10A inhibitor | 0.113 0.009 DBMET03650 | DBMET03650 | |
| 0.048 | 0.078 | 0.157 | Janus tyrosine kinase 3 inhibitor | 0.157 0.017 DBMET03650 | DBMET03650 | |
| 0.123 | 0.156 | 0.31 | I kappa B kinase epsilon inhibitor | 0.31 0.012 DBMET03650 | DBMET03650 | |
| 0.04 | 0.073 | 0.076 | Phosphodiesterase II inhibitor | 0.076 0.019 DBMET03650 | DBMET03650 | |
| 0.071 | 0.104 | 0.158 | Bromodomain-containing protein 2 inhibitor | 0.158 0.007 DBMET03650 | DBMET03650 | |
| 0.17 | 0.204 | 0.258 | Nootropic | 0.258 0.101 DBMET03650 | DBMET03650 | |
| 0.031 | 0.067 | 0.125 | Janus tyrosine kinase 1 inhibitor | 0.125 0.014 DBMET03650 | DBMET03650 | |
| 0.034 | 0.072 | 0.068 | Phosphodiesterase 2A inhibitor | 0.068 0.019 DBMET03650 | DBMET03650 | |
| 0.089 | 0.127 | 0.264 | Phosphodiesterase inhibitor | 0.264 0.02 DBMET03650 | DBMET03650 | |
| 0.056 | 0.099 | 0.124 | ALK inhibitor | 0.124 0.028 DBMET03650 | DBMET03650 | |
| 0.105 | 0.149 | 0.226 | Protein kinase (CK1) gamma 3 inhibitor | 0.226 0.035 DBMET03650 | DBMET03650 | |
| 0.051 | 0.095 | 0.114 | MAP3K7 inhibitor | 0.114 0.016 DBMET03650 | DBMET03650 | |
| 0.055 | 0.099 | 0.108 | Focal adhesion kinase 1 inhibitor | 0.108 0.025 DBMET03650 | DBMET03650 | |
| 0.087 | 0.133 | 0.192 | Ribosomal protein S6 kinase inhibitor | 0.192 0.04 DBMET03650 | DBMET03650 | |
| 0.036 | 0.082 | 0.082 | Pim-2 kinase inhibitor | 0.082 0.02 DBMET03650 | DBMET03650 | |
| 0.036 | 0.084 | 0.056 | Bromodomain-containing protein 4 inhibitor | 0.056 0.036 DBMET03650 | DBMET03650 | |
| 0.05 | 0.099 | 0.141 | TIE antagonist | 0.141 0.025 DBMET03650 | DBMET03650 | |
| 0.049 | 0.098 | 0.134 | TIE-2 antagonist | 0.134 0.026 DBMET03650 | DBMET03650 | |
| 0.087 | 0.137 | 0.275 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.275 0.031 DBMET03650 | DBMET03650 | |
| 0.063 | 0.116 | 0.169 | MAP kinase 9 inhibitor | 0.169 0.031 DBMET03650 | DBMET03650 | |
| 0.106 | 0.162 | 0.205 | LIM domain kinase 1 inhibitor | 0.205 0.06 DBMET03650 | DBMET03650 | |
| 0.075 | 0.131 | 0.337 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.337 0.012 DBMET03650 | DBMET03650 | |
| 0.119 | 0.178 | 0.382 | Dyrk kinase inhibitor | 0.382 0.03 DBMET03650 | DBMET03650 | |
| 0.049 | 0.111 | 0.126 | Platelet growth factor antagonist | 0.126 0.027 DBMET03650 | DBMET03650 | |
| 0.116 | 0.179 | 0.374 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.374 0.03 DBMET03650 | DBMET03650 | |
| 0.034 | 0.104 | 0.061 | Phosphatidylinositol kinase inhibitor | 0.061 0.04 DBMET03650 | DBMET03650 | |
| 0.024 | 0.094 | 0.056 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.056 0.032 DBMET03650 | DBMET03650 | |
| 0.039 | 0.112 | 0.136 | Janus tyrosine kinase 2 inhibitor | 0.136 0.024 DBMET03650 | DBMET03650 | |
| 0.056 | 0.129 | 0.093 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.093 0.045 DBMET03650 | DBMET03650 | |
| 0.073 | 0.148 | 0.198 | Epidermal growth factor receptor kinase inhibitor | 0.198 0.026 DBMET03650 | DBMET03650 | |
| 0.113 | 0.19 | 0.235 | Death-associated protein kinase 3 inhibitor | 0.235 0.058 DBMET03650 | DBMET03650 | |
| 0.05 | 0.128 | 0.119 | Stem cell growth factor agonist | 0.119 0.031 DBMET03650 | DBMET03650 | |
| 0.055 | 0.133 | 0.125 | Pim-1 kinase inhibitor | 0.125 0.039 DBMET03650 | DBMET03650 | |
| 0.023 | 0.104 | 0.05 | Bromodomain-containing protein 3 inhibitor | 0.05 0.034 DBMET03650 | DBMET03650 | |
| 0.043 | 0.127 | 0.135 | ErbB-2 antagonist | 0.135 0.023 DBMET03650 | DBMET03650 | |
| 0.046 | 0.135 | 0.074 | MAP kinase kinase 8 inhibitor | 0.074 0.041 DBMET03650 | DBMET03650 | |
| 0.064 | 0.154 | 0.179 | Cyclin-dependent kinase inhibitor | 0.179 0.044 DBMET03650 | DBMET03650 | |
| 0.02 | 0.11 | 0.055 | Adenosine A2b receptor antagonist | 0.055 0.029 DBMET03650 | DBMET03650 | |
| 0.026 | 0.119 | 0.067 | Potassium channel small-conductance Ca-activated blocker | 0.067 0.014 DBMET03650 | DBMET03650 | |
| 0.122 | 0.216 | 0.252 | Histone acetyltransferase inhibitor | 0.252 0.025 DBMET03650 | DBMET03650 | |
| 0.102 | 0.195 | 0.147 | Death-associated protein kinase 1 inhibitor | 0.147 0.043 DBMET03650 | DBMET03650 | |
| 0.092 | 0.187 | 0.246 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.246 0.047 DBMET03650 | DBMET03650 | |
| 0.021 | 0.117 | 0.049 | Phosphatidylinositol 3-kinase delta inhibitor | 0.049 0.048 DBMET03650 | DBMET03650 | |
| 0.027 | 0.124 | 0.071 | Cyclin A1 inhibitor | 0.071 0.021 DBMET03650 | DBMET03650 | |
| 0.047 | 0.146 | 0.132 | Epidermal growth factor antagonist | 0.132 0.028 DBMET03650 | DBMET03650 | |
| 0.023 | 0.122 | 0.086 | Raf kinase B inhibitor | 0.086 0.027 DBMET03650 | DBMET03650 | |
| 0.116 | 0.216 | 0.167 | Cyclin-dependent kinase 3 inhibitor | 0.167 0.064 DBMET03650 | DBMET03650 | |
| 0.146 | 0.247 | 0.273 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.273 0.085 DBMET03650 | DBMET03650 | |
| 0.063 | 0.166 | 0.218 | Vascular endothelial growth factor 3 antagonist | 0.218 0.036 DBMET03650 | DBMET03650 | |
| 0.032 | 0.136 | 0.116 | Raf kinase inhibitor | 0.116 0.026 DBMET03650 | DBMET03650 | |
| 0.06 | 0.165 | 0.074 | MAP kinase 7 inhibitor | 0.074 0.071 DBMET03650 | DBMET03650 | |
| 0.053 | 0.158 | 0.126 | MAP kinase 8 inhibitor | 0.126 0.04 DBMET03650 | DBMET03650 | |
| 0.042 | 0.149 | 0.137 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.137 0.032 DBMET03650 | DBMET03650 | |
| 0.054 | 0.161 | 0.243 | c-Src kinase inhibitor | 0.243 0.026 DBMET03650 | DBMET03650 | |
| 0.072 | 0.179 | 0.251 | CDC-like kinase 2 inhibitor | 0.251 0.045 DBMET03650 | DBMET03650 | |
| 0.051 | 0.159 | 0.111 | Polo-like kinase-4 inhibitor | 0.111 0.065 DBMET03650 | DBMET03650 | |
| 0.044 | 0.153 | 0.078 | Adenosine A3 receptor antagonist | 0.078 0.045 DBMET03650 | DBMET03650 | |
| 0.072 | 0.182 | 0.184 | CDC-like kinase 1 inhibitor | 0.184 0.045 DBMET03650 | DBMET03650 | |
| 0.076 | 0.188 | 0.182 | Protein kinase (CK1) gamma 1 inhibitor | 0.182 0.049 DBMET03650 | DBMET03650 | |
| 0.068 | 0.182 | 0.219 | Protein kinase (CK1) gamma inhibitor | 0.219 0.038 DBMET03650 | DBMET03650 | |
| 0.08 | 0.195 | 0.107 | Interleukin 2 antagonist | 0.107 0.071 DBMET03650 | DBMET03650 | |
| 0.047 | 0.162 | 0.212 | Vascular endothelial growth factor 1 antagonist | 0.212 0.024 DBMET03650 | DBMET03650 | |
| 0.039 | 0.157 | 0.122 | Bcr-Abl kinase inhibitor | 0.122 0.025 DBMET03650 | DBMET03650 | |
| 0.087 | 0.206 | 0.126 | Sphingosine 1-phosphate receptor 2 antagonist | 0.126 0.083 DBMET03650 | DBMET03650 | |
| 0.046 | 0.166 | 0.109 | CDK2/cyclin A inhibitor | 0.109 0.051 DBMET03650 | DBMET03650 | |
| 0.06 | 0.183 | 0.153 | Protein kinase (CK1) gamma 2 inhibitor | 0.153 0.048 DBMET03650 | DBMET03650 | |
| 0.048 | 0.172 | 0.18 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.18 0.034 DBMET03650 | DBMET03650 | |
| 0.047 | 0.172 | 0.179 | Abl kinase inhibitor | 0.179 0.034 DBMET03650 | DBMET03650 | |
| 0.065 | 0.2 | 0.147 | Hedgehog signaling inhibitor | 0.147 0.025 DBMET03650 | DBMET03650 | |
| 0.059 | 0.197 | 0.082 | Transforming growth factor beta 3 antagonist | 0.082 0.057 DBMET03650 | DBMET03650 | |
| 0.065 | 0.203 | 0.095 | CDC-like kinase 3 inhibitor | 0.095 0.092 DBMET03650 | DBMET03650 | |
| 0.083 | 0.221 | 0.115 | DNA repair enzyme inhibitor | 0.115 0.082 DBMET03650 | DBMET03650 | |
| 0.056 | 0.196 | 0.185 | Beta amyloid protein antagonist | 0.185 0.022 DBMET03650 | DBMET03650 | |
| 0.046 | 0.186 | 0.106 | Cyclin-dependent kinase 2 inhibitor | 0.106 0.064 DBMET03650 | DBMET03650 | |
| 0.031 | 0.173 | 0.081 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.081 0.051 DBMET03650 | DBMET03650 | |
| 0.038 | 0.182 | 0.094 | Myeloperoxidase inhibitor | 0.094 0.043 DBMET03650 | DBMET03650 | |
| 0.047 | 0.195 | 0.148 | Insulin receptor antagonist | 0.148 0.028 DBMET03650 | DBMET03650 | |
| 0.051 | 0.199 | 0.074 | Phosphodiesterase 11A inhibitor | 0.074 0.072 DBMET03650 | DBMET03650 | |
| 0.051 | 0.199 | 0.074 | Phosphodiesterase XI inhibitor | 0.074 0.072 DBMET03650 | DBMET03650 | |
| 0.062 | 0.214 | 0.135 | Protein kinase C nu inhibitor | 0.135 0.079 DBMET03650 | DBMET03650 | |
| 0.025 | 0.178 | 0.203 | Phosphodiesterase 4B inhibitor | 0.203 0.008 DBMET03650 | DBMET03650 | |
| 0.089 | 0.243 | 0.214 | Platelet aggregation inhibitor | 0.214 0.072 DBMET03650 | DBMET03650 | |
| 0.067 | 0.221 | 0.24 | Clk dual-specificity kinase inhibitor | 0.24 0.059 DBMET03650 | DBMET03650 | |
| 0.016 | 0.174 | 0.063 | Bruton tyrosine kinase inhibitor | 0.063 0.032 DBMET03650 | DBMET03650 | |
| 0.064 | 0.222 | 0.201 | CDC-like kinase 4 inhibitor | 0.201 0.067 DBMET03650 | DBMET03650 | |
| 0.052 | 0.212 | 0.254 | MAP kinase kinase inhibitor | 0.254 0.015 DBMET03650 | DBMET03650 | |
| 0.045 | 0.207 | 0.153 | EphA2 antagonist | 0.153 0.029 DBMET03650 | DBMET03650 | |
| 0.044 | 0.207 | 0.304 | Glycogen synthase kinase-3 alpha inhibitor | 0.304 0.016 DBMET03650 | DBMET03650 | |
| 0.101 | 0.271 | 0.143 | CC chemokine 6 receptor antagonist | 0.143 0.033 DBMET03650 | DBMET03650 | |
| 0.048 | 0.22 | 0.09 | Protein kinase C zeta inhibitor | 0.09 0.065 DBMET03650 | DBMET03650 | |
| 0.084 | 0.259 | 0.154 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.154 0.108 DBMET03650 | DBMET03650 | |
| 0.048 | 0.224 | 0.091 | GABA C receptor rho-1 antagonist | 0.091 0.076 DBMET03650 | DBMET03650 | |
| 0.058 | 0.236 | 0.164 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.164 0.063 DBMET03650 | DBMET03650 | |
| 0.01 | 0.204 | 0.046 | Inosine monophosphate dehydrogenase inhibitor | 0.046 0.017 DBMET03650 | DBMET03650 | |
| 0.048 | 0.245 | 0.145 | Toll-Like receptor 9 antagonist | 0.145 0.066 DBMET03650 | DBMET03650 | |
| 0.029 | 0.233 | 0.237 | MAP kinase kinase kinase inhibitor | 0.237 0.012 DBMET03650 | DBMET03650 | |
| 0.076 | 0.28 | 0.201 | Antiamyloidogenic | 0.201 0.099 DBMET03650 | DBMET03650 | |
| 0.058 | 0.266 | 0.223 | Pyruvate kinase inhibitor | 0.223 0.07 DBMET03650 | DBMET03650 | |
| 0.072 | 0.281 | 0.198 | Aldehyde oxidase inhibitor | 0.198 0.106 DBMET03650 | DBMET03650 | |
| 0.01 | 0.227 | 0.031 | Calcium release-activated channel blocker | 0.031 0.027 DBMET03650 | DBMET03650 | |
| 0.033 | 0.273 | 0.069 | Phosphodiesterase VI inhibitor | 0.069 0.065 DBMET03650 | DBMET03650 | |
| 0.039 | 0.283 | 0.128 | MAP kinase kinase 1 inhibitor | 0.128 0.028 DBMET03650 | DBMET03650 | |
| 0.029 | 0.274 | 0.107 | Glycogen synthase kinase-3 inhibitor | 0.107 0.073 DBMET03650 | DBMET03650 | |
| 0.031 | 0.279 | 0.12 | Cyclin-dependent kinase 9 inhibitor | 0.12 0.045 DBMET03650 | DBMET03650 | |
| 0.027 | 0.281 | 0.107 | Glycogen synthase kinase-3 beta inhibitor | 0.107 0.07 DBMET03650 | DBMET03650 | |
| 0.025 | 0.281 | 0.096 | Phosphodiesterase 3A inhibitor | 0.096 0.035 DBMET03650 | DBMET03650 | |
| 0.066 | 0.328 | 0.172 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.172 0.102 DBMET03650 | DBMET03650 | |
| 0.107 | 0.383 | 0.259 | ErbB-1 antagonist | 0.259 0.047 DBMET03650 | DBMET03650 | |
| 0.007 | 0.284 | 0.028 | MAP3K8 inhibitor | 0.028 0.022 DBMET03650 | DBMET03650 | |
| 0.013 | 0.298 | 0.061 | Protein kinase C theta inhibitor | 0.061 0.036 DBMET03650 | DBMET03650 | |
| 0.104 | 0.404 | 0.152 | MAP kinase kinase 5 inhibitor | 0.152 0.146 DBMET03650 | DBMET03650 | |
| 0.046 | 0.353 | 0.249 | MAP kinase kinase 2 inhibitor | 0.249 0.054 DBMET03650 | DBMET03650 | |
| 0.016 | 0.324 | 0.129 | Protein kinase (CK2) alpha inhibitor | 0.129 0.056 DBMET03650 | DBMET03650 | |
| 0.013 | 0.344 | 0.137 | Phosphodiesterase IV inhibitor | 0.137 0.026 DBMET03650 | DBMET03650 | |
| 0.058 | 0.399 | 0.196 | Tumour necrosis factor antagonist | 0.196 0.055 DBMET03650 | DBMET03650 | |
| 0.013 | 0.358 | 0.099 | Protein kinase (CK2) inhibitor | 0.099 0.065 DBMET03650 | DBMET03650 | |
| 0.023 | 0.396 | 0.096 | Protein kinase C gamma inhibitor | 0.096 0.085 DBMET03650 | DBMET03650 | |
| 0.036 | 0.433 | 0.123 | MAP3K9 inhibitor | 0.123 0.109 DBMET03650 | DBMET03650 | |
| 0.024 | 0.427 | 0.274 | Aryl hydrocarbon receptor agonist | 0.274 0.07 DBMET03650 | DBMET03650 | |
| 0.013 | 0.431 | 0.06 | Cyclin D1 inhibitor | 0.06 0.042 DBMET03650 | DBMET03650 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |